Acc International Holdings Ltd., Member of 10% owner group at Brainstorm Cell Therapeutics, holds 67.05K shares in Brainstorm Cell Therapeutics (Ticker: BCLI). Most recently, Acc International Holdings Ltd. Sold $71,753 shares of Brainstorm Cell Therapeutics on Jul 16, 2020 for an estimated value of 960.33K.